PMID: 6405383May 1, 1983Paper

Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide

Proceedings of the National Academy of Sciences of the United States of America
V I ZannisJ L Breslow

Abstract

We have recently proposed that the major secreted isoprotein form of human apolipoprotein A-I (designated apo A-I2) is modified extracellularly to become the predominant apo A-I form seen in plasma (designated apo A-I4). In the current report we demonstrate that the primary translation product of human apo A-I (designated apo A-I2p) has a 24-amino-acid NH2-terminal extension with a sequence of Met-Lys-Ala-Ala-Val-Leu-Thr-Leu-Ala-Val-Leu-Phe- Leu-Thr-Gly-Ser-Gln-Ala-Arg-His-Phe-Trp-Gln-Gln. The first 18 amino acids of this NH2-terminal extension are cleaved intracellularly by the signal peptidase, resulting in the formation of apo A-I2, which is the secreted form of apo A-I. Sequence analysis of apo A-I2 confirmed that it contains a hexapeptide extension at its NH2 terminus compared to apo A-I4. This observation demonstrates that apo A-I2 is a propeptide and that the apo A-I2 to apo A-I4 conversion involves the removal of the NH2-terminal hexapeptide of apo A-I2 by a protease in plasma, lymph, or both. Our findings indicate that apo A-I is synthesized as a prepropeptide, which undergoes intracellular and extracellular proteolysis to attain the major plasma apo A-I4 isoprotein form.

References

Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J F HabenerJ T Potts
Feb 1, 1978·The Journal of Clinical Investigation·P H GreenR M Glickman
Feb 14, 1978·Biochemical and Biophysical Research Communications·H B BrewerT J Bronzert
Oct 26, 1978·The New England Journal of Medicine·E J SchaeferH B Brewer
Aug 1, 1978·Atherosclerosis·G AssmannU Wellner
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Jun 1, 1978·The Journal of Clinical Investigation·G SchonfeldD H Alpers
Feb 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·Y Burstein, I Schechter
Aug 1, 1976·European Journal of Biochemistry·H R Pelham, R J Jackson
Feb 25, 1972·Biochemical and Biophysical Research Communications·C J FieldingP E Fielding
Oct 1, 1982·The Journal of Clinical Investigation·K M MorrisH R Colten
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J L BreslowV I Zannis
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D E WoodsH R Colten
Jan 1, 1980·CRC Critical Reviews in Biochemistry·M Inouye, S Halegoua
Jan 1, 1980·Annals of the New York Academy of Sciences·D F SteinerH S Tager
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S InouyeM Inouye
Jul 16, 1982·Biochemical and Biophysical Research Communications·G GhiselliH G Windmueller

❮ Previous
Next ❯

Citations

Sep 8, 2010·Biotechnology Letters·Pasquale ChiaieseEdgardo Filippone
Aug 12, 1988·Biochimica Et Biophysica Acta·S R WangR Infante
Oct 22, 1990·Biochimica Et Biophysica Acta·T YamamotoK Higashino
Sep 21, 1989·Biochimica Et Biophysica Acta·J L DixonD Banerjee
Jan 1, 1990·Biotechnology Advances·Y Murooka
Aug 4, 1998·FEBS Letters·J GenschelH H Schmidt
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G SchmitzR W Mahley
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S K KarathanasisJ L Breslow
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S S FojoH B Brewer
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·G SchmitzB Brennhausen
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·G GhiselliB C Sherrill
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R M GlickmanJ N Glickman
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A K SoutarJ J Hsuan
May 2, 1984·European Journal of Biochemistry·J E PoncinJ E Gielen
Apr 15, 1988·European Journal of Biochemistry·S C MakridesV I Zannis
Sep 9, 2011·Journal of Lipid Research·Godfrey S Getz, Catherine A Reardon
Jun 3, 1985·Klinische Wochenschrift·C R Sirtori, G Franceschini
Oct 31, 1983·Biochemical and Biophysical Research Communications·G GhiselliB C Sherrill
Aug 21, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Stefan P J DullensRonald P Mensink
May 15, 1987·Analytical Biochemistry·C LuleyH U Kloer
Feb 14, 1984·Biochemical and Biophysical Research Communications·S W LawS L Naylor
Oct 15, 1991·Biochemical and Biophysical Research Communications·J OsadaE Palacios-Alaiz
Apr 23, 2010·Neurobiology of Aging·Aaron J TrachtenbergClare E Mackay
Sep 22, 2010·Progress in Lipid Research·Paul S HauserRobert O Ryan
Nov 5, 2013·Neuroscience and Biobehavioral Reviews·Sana SuriClare E Mackay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hoppe-Seyler's Zeitschrift für physiologische Chemie
W StoffelK Knyrim
Proceedings of the National Academy of Sciences of the United States of America
S K KarathanasisJ L Breslow
Proceedings of the National Academy of Sciences of the United States of America
J L BreslowV I Zannis
© 2021 Meta ULC. All rights reserved